Effectiveness of a Proprioceptive Neuromuscular Proprioceptive Neuromuscular Facilitation

May 24, 2023 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Effectiveness of a Proprioceptive Neuromuscular With One of Eccentric Exercise Plus Acute Electrostimulation in the Eccentric Exercise Plus Acute Electrostimulation on the Weight Bearing Weight Bearing Lunge, Lateral Step Down and Drop Jump Tests in Drop Jump Test, in Professional Paddle Tennis Players

Introduction: Paddle tennis is a popular sport which can cause lower limb injuries due to impaired flexibility, such as ankle dorsiflexion. To improve this, methods such as proprioceptive neuromuscular facilitation (PNF), eccentric exercises and electrical stimulation (NMES) can be used. Objective: To compare the effectiveness of a PNF program with one of eccentric exercise plus NMES in the weight bearing lunge, lateral step down and drop jump test in amateur paddle tennis players. Methods: Pilot randomized clinical trial involving 20 male amateur paddle tennis players.

Participants were randomly divided into two groups of ten. One group received a PNF protocol, while the another group was given an Eccentric+ NMES exercise protocol. During the study, range of dorsal ankle flexion (ROMDf) was measured, as well as the vertical jump and lateral step down capacity of the participants.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Ávila, Spain, 05005
        • Jorge Velázquez Saornil

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be a professional padel player.
  • Be over 18 years of age.
  • Sign the informed consent to participate in the study.
  • Completion of the IPAQ physical activity questionnaire (Annex 1) to assess the level of physical activity of the participants and to ensure that they meet the physical activity level of the participants and to ensure that they meet the requirements for requirements for participation in the study.

Exclusion Criteria:

  • Traumatic or musculoskeletal history that may affect the performance of the study exercises, as determined in the exercises of the study.
  • A neurological history that may cause impairment in the performance of the exercises.
  • Use of orthoses that may generate alterations in the result.
  • Difficulty in performing exercises as determined by the Physical Activity Readiness Questionnaire (PAR-Q)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: proprioceptive neuromuscular facilitation group.
Proprioception protocol for ankle dorsiflexion.
Other: proprioceptive neuromuscular facilitation
proprioceptive neuromuscular facilitation to improve ankle dorsiflexion in professional padel players.
Experimental: Eccentric exercises and electrical stimulation group.
Eccentric exercises and strengthening currents for ankle dorsiflexion.
Other: eccentric exercises and electrical stimulation
Eccentric exercises and strengthening currents to improve ankle dorsiflexion in professional padel players.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
range of flexion ankle dorsiflexion
Time Frame: 1 month
using the weight bearing lunge test. Once the maximum distance has been reached, we perform the measurement with the clinometer application, we calibrate the the inclinometer at the verticality of your tibia, precisely at the proximal third and measure the range of motion of the ankle, not the position reached.
1 month
Vertical jump
Time Frame: 1 month

The protocol for the drop jump test proposes different heights ranging from 20 to 100 cm.

cm to 100 cm. In our study, there is a height of 25 cm to assess knee valgus, which is considered optimal according to the literature.

knee valgus, which is considered optimal according to the literature. The athlete, once on the The athlete, once on the box, should place his hands on his hips and drop from the top of the bench, cushion the impact and, once in the jumping position, perform a maximum vertical jump.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Católica de Ávila

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

March 1, 2023

Study Completion (Actual)

May 15, 2023

Study Registration Dates

First Submitted

May 15, 2023

First Submitted That Met QC Criteria

May 23, 2023

First Posted (Actual)

May 24, 2023

Study Record Updates

Last Update Posted (Actual)

May 26, 2023

Last Update Submitted That Met QC Criteria

May 24, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 15/05/2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe